Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
Total Revenue | 1,188,955 | 1,116,564 | 1,201,457 | 1,338,199 |
Cost of Revenue | 1,019,873 | 942,594 | 1,014,046 | 1,112,832 |
Gross Profit | 169,082 | 173,970 | 187,411 | 225,367 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | -- | -- | -- | -- |
Non Recurring | -- | -- | -- | -- |
Others | 151,730 | 150,212 | 161,807 | 170,737 |
Total Operating Expenses | 151,730 | 150,212 | 161,807 | 170,737 |
Operating Income or Loss | 17,352 | 23,758 | 25,604 | 54,630 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (1,784) | (4,728) | 2,469 | 1,099 |
Earnings Before Interest And Taxes | 20,323 | 22,854 | 21,866 | 51,447 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (4,827) | 878 | (4,104) | 27,208 |
Income Tax Expense | (1,528) | 3,209 | (1,203) | 8,297 |
Minority Interest | 18,460 | 21,499 | 22,392 | 21,727 |
Net Income From Continuing Ops | (3,299) | (2,331) | (2,901) | 18,911 |
Non-recurring Events | ||||
Discontinued Operations | 8,383 | (12,224) | 19,668 | (32) |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (205) | 954 | (665) | (1,522) |
Net Income | 4,879 | (13,601) | 16,102 | 17,357 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 4,879 | (13,601) | 16,102 | 17,357 |